Renata Trentin Perdomo

Dr. Renata Trentin Perdomo


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
GIOVANA BICUDO GOMESGIOVANA BICUDO GOMES
GIOVANA BICUDO GOMES
CZClaudia Stutz Zubieta
Claudia Stutz Zubieta
JGJhefferson Guilhermi
Jhefferson Guilhermi
MTMônica Toffoli-Kadri
Mônica Toffoli-Kadri
ABAdilson Beatriz
Adilson Beatriz
RPRenata Trentin Perdomo
Renata Trentin Perdomo
Colon cancer incidence rates are increasing annually, a scenario aggravated by genetic and epigenetic alterations that promote drug resistance. Recent studies showed that novel synthetic selenium compounds are more efficient and less toxic than conventional drugs, demonstrating biocompatibility and pro-oxidant effects on tumor cells. This study aimed to investigate the cytotoxic effect of MRK-107, an imidazo [1,2- a]pyridine derivative, in 2D and 3D cell culture models of colon cancer (Caco-2 and HT-29). Sulforhodamine B results revealed a GI50 of 2.4 µM for Caco-2, 1.1 µM for HT-29, and 22.19 µM for NIH/3T3 in 2D cultures after 48 h of treatment. Cell recovery, migration, clonogenic, and Ki-67 results corroborated that MRK-107 inhibits cell proliferation and prevents cell regeneration and metastatic transition by selectively reducing migratory and clonogenic capacity; non-tumor cells (NIH/3T3) re-established proliferation in less than 18 h. The oxidative stress markers DCFH-DA and TBARS revealed increased ROS generation and oxidative damage. Caspases-3/7 are activated and induce apoptosis as the main mode of cell death in both cell models, as assessed by annexin V-FITC and acridine orange/ethidium bromide staining. MRK-107 is a selective, redox-active compound with pro-oxidant and pro-apoptotic properties and the capacity to activate antiproliferative pathways, showing promise in anticancer drug research.

16 January 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
ELEstela Mariana Guimarães Lourenço
Estela Mariana Guimarães Lourenço
JIJuliana Fortes Di Iório
Juliana Fortes Di Iório
FSFernanda da Silva
Fernanda da Silva
FFFelipe Leonardo Bley Fialho
Felipe Leonardo Bley Fialho
MMMelquisedeque Mateus Monteiro
Melquisedeque Mateus Monteiro
DLDênis Pires de Lima
Dênis Pires de Lima
Leishmaniasis is a neglected tropical disease, affecting more than 350 million people globally. However, there is currently no vaccine available against human leishmaniasis, and current treatment is hampered by high cost, side-effects, and painful administration routes. It has become a United Nations goal to end leishmaniasis epidemics by 2030, and multitarget drug strategy emerges as a promising alternative. Among the multitarget compounds, flavonoids are a renowned class of natural products, and a structurally diverse library can be prepared through organic synthesis, which can be tested for biological effectiveness. In this study, we synthesised 17 flavonoid analogues using a scalable, easy-to-reproduce, and inexpensive method. All synthesised compounds presented an impressive inhibition capacity against rCPB2.8, rCPB3, and rH84Y enzymes, which are highly expressed in the amastigote stage, the target form of the parasite. Compounds 3c, f12a, and f12b were found to be effective against all isoforms. Furthermore, their intermolecular interactions were also investigated through a molecular modelling study. These compounds were highly potent against the parasite and demonstrated low cytotoxic action against mammalian cells. These results are pioneering, representing an advance in the investigation of the mechanisms behind the antileishmanial action of flavonoid derivatives. Moreover, compounds have been shown to be promising leads for the design of other cysteine protease inhibitors for the treatment of leishmaniasis diseases.

3 March 2025 in Redox Report
Verified
Journal Article
Open access
PCPaola Mayara Valente Coronel
Paola Mayara Valente Coronel
DBDenise Caroline Luiz Soares Basilio
Denise Caroline Luiz Soares Basilio
IEIsabelly Teixeira Espinoça
Isabelly Teixeira Espinoça
KSKamylla Fernanda Souza de Souza
Kamylla Fernanda Souza de Souza
NCNathalia Miranda Campos
Nathalia Miranda Campos
EPEduardo Benedetti Parisotto
Eduardo Benedetti Parisotto
Oxidative stress (OS) plays a key role in the pathophysiology of COVID-19 and may be associated with sequelae after severe SARS-CoV-2 infection. This study evaluated OS and inflammation biomarkers in blood from individuals with post-acute sequelae of COVID-19 (PASC). 64 male and female participants were distributed into three groups: healthy individuals (n = 20), acute COVID-19 patients (symptoms for 12 weeks, n = 29). Analyses included inflammatory cytokines, myeloperoxidase (MPO) activity, and OS markers, such as superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase (GST), gamma-glutamyl transferase (GGT), reduced glutathione (GSH), uric acid (UA), thiobarbituric acid reactive substances (TBARS), and protein carbonyls (PC). Individuals with PASC showed increased IL-6 and IL-8. Both COVID-19 groups exhibited decreased SOD and CAT. GST decreased only in the acute group. Elevated GGT and GSH were found in the PASC group. High UA levels were observed in PASC individuals. There were no changes in TBARS values ⁣⁣in the PASC group. However, PC concentrations were elevated only in this group. Correlations were identified between inflammatory markers and OS parameters. These findings suggest that individuals with PASC pronounced OS, which potentially exacerbates disease complications. Monitoring OS biomarkers could aid in patient prognosis and management.

9 September 2023 in Microbial Pathogenesis
Verified
Journal Article
Closed access
PCPaola Mayara Valente Coronel
Paola Mayara Valente Coronel
IPIndiara Correia Pereira
Indiara Correia Pereira
DBDenise Caroline Luiz Soares Basilio
Denise Caroline Luiz Soares Basilio
IEIsabelly Teixeira Espinoça
Isabelly Teixeira Espinoça
KSKamylla Fernanda Souza de Souza
Kamylla Fernanda Souza de Souza
EPEduardo Benedetti Parisotto
Eduardo Benedetti Parisotto

1 February 2021 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
KSKamylla Fernanda Souza de Souza
Kamylla Fernanda Souza de Souza
DTDanilo Tófoli
Danilo Tófoli
IPIndiara Correia Pereira
Indiara Correia Pereira
KFKelly Juliana Filippin
Kelly Juliana Filippin
AGAna Tereza Gomes Guerrero
Ana Tereza Gomes Guerrero
RPRenata Trentin Perdomo
Renata Trentin Perdomo

Verified
Journal Article
Open access
PDF file
FSFernanda da Silva
Fernanda da Silva
YRYasmin Silva Rizk
Yasmin Silva Rizk
ANAmarith Rodrigues das Neves
Amarith Rodrigues das Neves
ELEstela Mariana Guimarães Lourenço
Estela Mariana Guimarães Lourenço
AFAlda Maria Teixeira Ferreira
Alda Maria Teixeira Ferreira
Carla ArrudaCarla Arruda
Carla Arruda
Leishmaniases are neglected diseases with limited therapeutic options. Diffuse cutaneous leishmaniasis can occur in Brazil due to Leishmania amazonensis. This study details the antileishmanial activity and cytotoxicity of complexes of sodium usnate (SAU) with lanthanide ions ([LnL3 (H2O)x] (Ln = La(III), Nd(III), Gd(III), Tb(III), Eu(III) and Sm(III); L = SAU). All lanthanide complexes were highly active and more potent than SAU against L. amazonensis promastigotes and intracellular amastigotes (Pro: IC50 < 1.50 μM; Ama: IC50 < 7.52 μM). EuL3·3H2O and NdL3·3H2O were the most selective and effective on intracellular amastigotes, with a selectivity index of approximately 7.0. In silico predictions showed no evidence of mutagenicity, tumorigenicity or irritation for all complexes. Treatment with EuL3·3H2O triggered NO release even at the lowest concentration, indicating NO production as a mechanism of action against the parasite. Incubating promastigotes with the lanthanide complexes, particularly with SmL3·4H2O and GdL3·3H2O, led to a change in the mitochondrial membrane potential, indicating the ability of these complexes to target this essential organelle. The same complexes caused cell death through cell membrane disruption, but their relationship with early or late apoptotic processes remains unclear. Thus, the inclusion of lanthanide ions in SAU improves selectivity with a promising mechanism of action targeting the mitochondria.